CURE Performance — Direxion Daily Healthcare Bull 3X Shares
Data updated: 2026-09-28
CURE returned +6.98% year to date and +71.40% over one year to Jul 2026. Annualised returns are +6.41% over 3 years and +0.76% over 5 years. Against its Trading - Leveraged category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $120, against $136 for the category, and to $171 over one year, against $105. Volatility over the past three years was 42.46% a year. In the 12 months to Jul 2026 the fund lost a net $64.6M, and assets reached $171.74M.
CURE Growth of $100
What $100 invested in Direxion Daily Healthcare Bull 3X Shares grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | CURE | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $171 | $105 |
| 3 years (Aug 2023 – Jul 2026) | $120 | $136 |
| 5 years (Aug 2021 – Jul 2026) | $104 | $130 |
| Since data start (Aug 2019 – Jul 2026) | $237 | $147 |
CURE Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.98% |
| 1 year | +71.40% |
| 3 years (annualised) | +6.41% |
| 5 years (annualised) | +0.76% |
CURE Annual Returns
Calendar-year total returns of Direxion Daily Healthcare Bull 3X Shares, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.98% |
| 2025 | +22.39% |
| 2024 | −8.51% |
| 2023 | −9.76% |
| 2022 | −20.37% |
| 2021 | +87.45% |
| 2020 | +5.12% |
| 2019 (Aug–Dec) | +39.63% |
CURE Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.4% | +9.7% | −23.7% | −2.8% | +6.3% | +19.0% | +5.4% | — | — | — | — | — |
| 2025 | +20.0% | +3.3% | −6.2% | −13.8% | −18.1% | +4.7% | −11.1% | +15.2% | +4.0% | +9.6% | +28.8% | −5.3% |
| 2024 | +8.0% | +8.6% | +6.0% | −15.8% | +5.8% | +4.7% | +6.5% | +14.1% | −6.1% | −14.4% | −0.7% | −18.7% |
| 2023 | −6.7% | −14.2% | +5.1% | +8.1% | −13.4% | +12.1% | +1.7% | −3.4% | −9.8% | −10.6% | +15.5% | +11.9% |
| 2022 | −19.6% | −3.9% | +16.3% | −14.9% | +2.9% | −9.5% | +9.0% | −17.4% | −9.3% | +29.5% | +13.5% | −7.0% |
| 2021 | +3.4% | −6.6% | +11.4% | +11.8% | +5.4% | +6.6% | +14.9% | +6.7% | −16.3% | +15.5% | −9.1% | +28.6% |
| 2020 | −8.7% | −20.2% | −25.6% | +37.7% | +9.1% | −9.0% | +16.2% | +7.7% | −7.5% | −11.7% | +24.3% | +11.6% |
| 2019 | — | — | — | — | — | — | — | −3.1% | −1.2% | +14.9% | +15.0% | +10.4% |
CURE Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 42.46%
- 3-year Sharpe ratio: 0.05 (vs 4.5% risk-free rate)
- Best month: +28.81% (Nov 2025)
- Worst month: −23.65% (Mar 2026)
CURE Fund Flows
Monthly money in and out of Direxion Daily Healthcare Bull 3X Shares, from SEC Form N-PORT.
- 12-month net flow: −$64.6M
- 12-month gross sales (incl. reinvestments): $53.6M
- Sales ÷ redemptions: 0.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $6.3M | −$6.3M |
| Jun 2026 | $0 | $15.2M | −$15.2M |
| May 2026 | $9.0M | $0 | $9.0M |
| Apr 2026 | $13.0M | $0 | $13.0M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $11.3M | −$11.3M |
| Jan 2026 | $0 | $11.3M | −$11.3M |
| Dec 2025 | $0 | $16.5M | −$16.5M |
| Nov 2025 | $0 | $25.1M | −$25.1M |
| Oct 2025 | $0 | $8.7M | −$8.7M |
| Sep 2025 | $3.9M | $0 | $3.9M |
| Aug 2025 | $27.7M | $23.8M | $3.9M |
CURE Assets Under Management
Net assets of Direxion Daily Healthcare Bull 3X Shares by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $171.74M |
| 2026-04-30 | $138.30M |
| 2026-01-31 | $164.92M |
| 2025-10-31 | $183.29M |
| 2025-07-31 | $136.57M |
| 2025-04-30 | $133.26M |
| 2025-01-31 | $198.73M |
| 2024-10-31 | $153.90M |
| 2024-07-31 | $199.37M |
| 2024-04-30 | $179.92M |
| 2024-01-31 | $191.65M |
| 2023-10-31 | $154.06M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.